DIN 02556898 — POMBILITI 105 MG
POMBILITI is a powder for solution of Cipaglucosidase alfa marketed by AMICUS THERAPEUTICS CANADA INC.. The full Cipaglucosidase alfa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02556898
- Brand name
- POMBILITI
- Active ingredient
- Cipaglucosidase alfa
- Strength
- 105 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- AMICUS THERAPEUTICS CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Enzyme replacement therapy (lysosomal enzyme)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.